Exercise Program for Early-Stage Hormone-Positive Breast Cancer
Part of Cancer, Skin clinical trials.
This study tests whether a structured exercise program helps women with early-stage hormone-positive breast cancer who are taking endocrine therapy (hormone-blocking medications). The goal is to see if physical activity improves outcomes and quality of life during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Have early-stage (stage 1–3a) breast cancer that is hormone receptor-positive
- Be female and at least 18 years old
- Be taking endocrine therapy (hormone-blocking medication) as your main cancer treatment
- Not be receiving chemotherapy for your breast cancer
- Be able to participate in the Andos Pordenone exercise program
- Not have advanced or metastatic (spread) breast cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a supervised physical activity program can help breast cancer patients reduce inflammation and improve health during neoadjuvant treatment (chemotherapy or immunotherapy given before surgery). The goal is to see if exercise can improve treatment outcomes and overall well-being.
This study tests whether supervised exercise during chemotherapy is safe and helpful for people with early-stage breast cancer. It may support physical function and well-being while you are receiving cancer treatment.
This trial tests whether a program of supervised exercise and full follow-up before and after breast cancer treatment can improve recovery and quality of life for women with early-stage breast cancer.
This trial tests whether starting a gentle exercise program early can help prevent or reduce joint and muscle pain caused by aromatase inhibitors (a common breast cancer medicine). It is for women with hormone-sensitive breast cancer who are not yet experiencing severe pain from their treatment.
This study looks at how a supervised exercise program affects muscle-related substances (myokines) in women who have finished breast cancer treatment. It may help understand how exercise can support recovery.
This trial tests whether a supervised exercise program can help women with triple-negative breast cancer who are receiving chemotherapy. It may help manage side effects and improve well-being during treatment.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.